703674001: Dapagliflozin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with cellular transport inhibitor mechanism of action (substance)\Sodium glucose cotransporter subtype 2 inhibitor\Dapagliflozin (substance)

\Drug or medicament (substance)\Dapagliflozin (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure\Organic compound\Substance with ether structure (substance)\Dapagliflozin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dapagliflozin (substance)	Is a	Sodium glucose cotransporter subtype 2 inhibitor	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Dapagliflozin (substance)	Has disposition	Sodium glucose cotransporter subtype 2 inhibitor (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Dapagliflozin (substance)	Is a	Substance with ether structure (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Dapagliflozin (substance)	Is a	Drug or medicament (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dapagliflozin propanediol (substance)	Is a	False	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing dapagliflozin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dapagliflozin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dapagliflozin propanediol (substance)	Is modification of (attribute)	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Dapagliflozin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only dapagliflozin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dapagliflozin (as dapagliflozin propanediol monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dapagliflozin (as dapagliflozin propanediol monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dapagliflozin- and metformin- and saxagliptin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Dapagliflozin and metformin and saxagliptin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing only dapagliflozin and metformin and saxagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Dapagliflozin- and metformin- and saxagliptin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Dapagliflozin (as dapagliflozin propanediol) 10 mg oral tablet	Has basis of strength substance (attribute)	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Allergy to dapagliflozin (finding)	Causative agent (attribute)	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Dapagliflozin (as dapagliflozin propanediol) 5 mg and metformin hydrochloride 850 mg oral tablet	Has basis of strength substance (attribute)	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing dapagliflozin and metformin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing dapagliflozin and metformin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only dapagliflozin and metformin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Dapagliflozin and metformin only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 10 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only dapagliflozin and saxagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing dapagliflozin and saxagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Dapagliflozin and saxagliptin only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Dapagliflozin- and saxagliptin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3008942010	Dapagliflozin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3009235014	Dapagliflozin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3008942010	Dapagliflozin (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3008942010	Dapagliflozin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3009235014	Dapagliflozin	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3009235014	Dapagliflozin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
365921000195116	dapagliflozin	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
67751000195116	Dapagliflozin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
803821000172115	dapagliflozine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
803821000172115	dapagliflozine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
52881000195114	dapaglifozin	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
365921000195116	dapagliflozin	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
67751000195116	Dapagliflozin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module